TRANSFORMING DISEASE PREVENTION THROUGH INNOVATIVE INVESTMENT MODELS: DEVELOPMENT OF A TYPOLOGY AND TOOLKIT TO SUPPORT SUSTAINABLE PREVENTION FINANCING
Author(s)
Balázs Babarczy, PhD1, Maureen Rutten-van Mölken, Sr., PhD2, Lucas Goossens, PhD3, Apostolos Tsiachristas, PhD4, Sarah Wordsworth, BSc, MSc, PhD4, Rositsa Koleva-Kolarova, BSc, MSc, PhD5, Emily Hulse, PhD6, Rhiannon Tudor Edwards, PhD7, Jacob R. Davies, BSc7, Stephen Wright, M.Litt.8, Stefánia B. Plankó, MSc1, Julia Zemplenyine Bartha, MSc1, Antal T. Zemplenyi, MSc, PhD9, Balázs Nagy, PhD1;
1Syreon Research Institute, Budapest, Hungary, 2Erasmus University, Rotterdam, Netherlands, 3Erasmus University, ESHPM/iMTA, Rotterdam, Netherlands, 4University of Oxford, Oxford, United Kingdom, 5Health Economics Research Centre, University of Oxford, Oxford, United Kingdom, 6University of Oxford, Blavatnik School of Government, Oxford, United Kingdom, 7Bangor University, Bangor, United Kingdom, 8Stichting HealthclusterNET, Amsterdam, Netherlands, 9University of Colorado Skaggs School of Pharmacy and Pharmaceutical Science, Denver, CO, USA
1Syreon Research Institute, Budapest, Hungary, 2Erasmus University, Rotterdam, Netherlands, 3Erasmus University, ESHPM/iMTA, Rotterdam, Netherlands, 4University of Oxford, Oxford, United Kingdom, 5Health Economics Research Centre, University of Oxford, Oxford, United Kingdom, 6University of Oxford, Blavatnik School of Government, Oxford, United Kingdom, 7Bangor University, Bangor, United Kingdom, 8Stichting HealthclusterNET, Amsterdam, Netherlands, 9University of Colorado Skaggs School of Pharmacy and Pharmaceutical Science, Denver, CO, USA
OBJECTIVES: Despite strong evidence of its effectiveness, investment in prevention and health promotion is limited. The EU-funded Invest4Health (I4H) project seeks to align prevention initiatives with innovative and sustainable investment structures involving public and private actors. This study presents a typology and a decision-support toolkit to aid in the design and implementation of these models.
METHODS: A scoping review of grey and peer-reviewed literature was conducted to identify existing innovative investment and funding approaches relevant to prevention and health promotion. Semi-structured expert interviews with investors, health policy representatives, and researchers were carried out to better understand current practices and gaps. The tools developed based on these findings were applied and iteratively refined through collaboration with six national or regional test beds in Europe: Galicia in Spain, West Wales in the United Kingdom, Skåne and Jönköping in Sweden, North Rhine-Westphalia in Germany, and Italy.
RESULTS: The toolkit consists of: (1) a stakeholder visualization tool mapping actors and resource flows; (2) a value matrix to align project value propositions with investor and commissioner expectations; (3) a flowchart of available investment and financing model options; and (4) a detailed typology to customize selected models. As a result of the iterative investment and funding model development process, 2-3 core alternatives were identified in each case, including traditional public funding, community investment and outcomes-based external investment models. Each of these is described including scope, partnership structures, contractual arrangements, outcomes, risk profiles, feasibility, and scalability.
CONCLUSIONS: This study presents policy-oriented typology and practical toolkit to support sustainable financing of prevention and health promotion initiatives. By clarifying financing options and trade-offs, it provides decision makers with a structured approach to mobilizing investment in prevention. While developed in a European context, the toolkit is adaptable to other health system settings.
METHODS: A scoping review of grey and peer-reviewed literature was conducted to identify existing innovative investment and funding approaches relevant to prevention and health promotion. Semi-structured expert interviews with investors, health policy representatives, and researchers were carried out to better understand current practices and gaps. The tools developed based on these findings were applied and iteratively refined through collaboration with six national or regional test beds in Europe: Galicia in Spain, West Wales in the United Kingdom, Skåne and Jönköping in Sweden, North Rhine-Westphalia in Germany, and Italy.
RESULTS: The toolkit consists of: (1) a stakeholder visualization tool mapping actors and resource flows; (2) a value matrix to align project value propositions with investor and commissioner expectations; (3) a flowchart of available investment and financing model options; and (4) a detailed typology to customize selected models. As a result of the iterative investment and funding model development process, 2-3 core alternatives were identified in each case, including traditional public funding, community investment and outcomes-based external investment models. Each of these is described including scope, partnership structures, contractual arrangements, outcomes, risk profiles, feasibility, and scalability.
CONCLUSIONS: This study presents policy-oriented typology and practical toolkit to support sustainable financing of prevention and health promotion initiatives. By clarifying financing options and trade-offs, it provides decision makers with a structured approach to mobilizing investment in prevention. While developed in a European context, the toolkit is adaptable to other health system settings.
Conference/Value in Health Info
2026-05, ISPOR 2026, Philadelphia, PA, USA
Value in Health, Volume 29, Issue S6
Code
EPH84
Topic
Epidemiology & Public Health
Topic Subcategory
Public Health
Disease
No Additional Disease & Conditions/Specialized Treatment Areas